CAS 401907-26-4: N-[4-[3-(4-tert-Butylbenzyl)thioureidomethyl]-2-fluorophenyl]methanesulfonamide
Fórmula:C20H26FN3O2S2
- Sinónimos:
- Pac-20030
- Sc-0030
- Jyl-1421
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | JYL1421 REF: 3D-BRA90726CAS: 401907-26-4 | Min. 95% | 344,00 €~2.896,00 € | Jue 08 May 25 |
 | JYL 1421 REF: TM-T15634CAS: 401907-26-4 | 98.83% | 70,00 €~1.985,00 € | Jue 15 May 25 |
JYL1421
CAS:401907-26-4
JYL1421 is a potential drug target for the treatment of chronic cough, inflammatory bowel disease, …
Fórmula:
C20H26FN3O2S2
Pureza:
Min. 95%
Peso molecular:
423.57 g/mol
Ref: 3D-BRA90726
| 1mg | 344,00 € | ||
| 5mg | 673,00 € | ||
| 10mg | 1.026,00 € | ||
| 25mg | 1.810,00 € | ||
| 50mg | 2.896,00 € |
Entrega estimada en Estados Unidos, el Jueves 8 de Mayo de 2025
JYL 1421
CAS:401907-26-4
JYL 1421 (SC 0030) is an antagonist of TRPV1 receptor (IC50 = 8 nM).
Fórmula:
C20H26FN3O2S2
Pureza:
98.83%
Forma y color:
Solid
Peso molecular:
423.57
Ref: TM-T15634
| 1mg | 70,00 € | ||
| 5mg | 187,00 € | ||
| 10mg | 305,00 € | ||
| 25mg | 612,00 € | ||
| 50mg | 938,00 € | ||
| 100mg | 1.491,00 € | ||
| 200mg | 1.985,00 € | ||
| 1mL*10mM (DMSO) | 173,00 € |
Entrega estimada en Estados Unidos, el Jueves 15 de Mayo de 2025
